The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
A model for a new pyramid of prenatal care based on the 11 to 13 weeks' assessment
Open accessAbstract
One century ago it was recognized that with the methods and material at our disposal we were not making all the progress possible toward solving many problems of prenatal diagnosis and treatment (Ballantyne, 1901, 1921). In order to achieve these objectives it was urged that a new means of investigation should be undertaken which had not yet been tried, at least not yet attempted on a large scale and in a systematic fashion. This led to the introduction of prenatal care which constituted a major advance in the care of pregnant women and played a pivotal role in the substantial reduction in maternal and perinatal mortality achieved during the last century. In 1929, the Ministry of Health in the UK issued a Memorandum on Antenatal Clinics recommending that women should first be seen at 16 weeks, then at 24 and 28 weeks, fortnightly thereafter until 36 weeks and then weekly until delivery (Figure 1) (Ministry of Health Report, 1929). No explicit rationale was offered for either the timing or clinical content of visits, yet these guidelines established the pattern of prenatal care to be followed throughout the world until now. The high concentration of visits in the late third trimester implies that most complications occur toward the end of pregnancy and most adverse outcomes cannot be predicted from the first trimester. However, is this really the case? Scientific advances in the last 20 years have raised the hope that many pregnancy complications are potentially detectable from at least as early as the 12th week of gestation. It has become apparent that most major aneuploidies can be identified at 11 to 13 weeks' gestation by a combination of maternal characteristics, ultrasound findings and biochemical testing of maternal blood. It is also becoming increasingly apparent that an integrated first hospital visit at 11 to 13 weeks combining data from maternal characteristics and history with findings of biophysical and biochemical tests can define the patient-specific risk for a wide spectrum of pregnancy complications, including miscarriage and fetal death, preterm delivery, preeclampsia, gestational diabetes, fetal growth restriction and macrosomia. Pyramid of prenatal care: past (left) and future (right) We have learnt that about 90% of fetuses with major aneuploidies can be identified by a combination of maternal age, fetal nuchal translucency (NT) thickness and maternal serum-free ß-hCG and PAPP-A at 11 to 13 weeks (Nicolaides, 2011). Improvement in the performance of first-trimester screening can be achieved by first carrying out the biochemical test at 9 to 10 weeks and the ultrasound scan at 12 weeks and second, inclusion in the ultrasound examination assessment of the nasal bone and flow in the ductus venosus, hepatic artery and across the tricuspid valve. A similar performance of screening can be achieved by examining the additional ultrasound markers in all cases and by a contingent policy in which first-stage combined screening classifies the patients as high-, intermediate- and low-risk and the new markers are examined only in the intermediate-risk group which is then reclassified as low- or high-risk. We have learnt that at the 11 to 13 weeks' scan it is possible to diagnose or suspect the presence of most major abnormalities, which are either lethal or associated with severe handicap, so that the parents can have the option of earlier and safer pregnancy termination. Major fetal abnormalities fall into essentially three groups in relation to whether they can be detected at the 11 to 13 weeks' scan (Syngelaki et al., 2011): first, those which are always detectable abnormalities, including body stalk anomaly, anencephaly, alobar holoprosencephaly, exomphalos, gastroschisis and megacystis and second, undetectable abnormalities because sonographic signs are only manifest during the second or third trimester of pregnancy, including some brain abnormalities, such as microcephaly, hypoplasia of the cerebellum or vermis, hydrocephalus and agenesis of the corpus callosum, achondroplasia, echogenic lung lesions, many renal anomalies and bowel obstruction. A third group includes abnormalities that are potentially detectable depending on first the objectives set for such a scan and consequently the time allocated for the fetal examination, the expertise of the sonographer and the quality of the equipment used and second, the presence of an easily detectable marker for an underlying abnormality. Good examples of such markers in the first trimester include high NT in some fetuses with lethal skeletal dysplasias (Khalil et al., 2011) and diaphragmatic hernia, high NT and abnormal flow in the ductus venosus and across the tricuspid valve in major cardiac defects (Chelemen et al., 2011) and increase in brain stem diameter with decrease in the diameter of the fourth ventricle-cisterna magna complex in open spina bifida (Lachmann et al., 2011). We have learnt that the rates of miscarriage and stillbirth after demon
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Screening for type 2 diabetes: literature review and economic modelling
Waugh, N., Scotland, G., McNamee, P., Gillett, M., Brennan, A., Goyder, E., Williams, R., & John, A. (2007) · Health Technology Assessment · doi:10.3310/hta11170 · Cited by 298
Cited by
Ashoor, G., Syngelaki, A., Wagner, M., Birdir, C., & Nicolaides, K. H. (2012) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2012.01.029 · Cited by 325
Self-citationKarim, J. N., Roberts, N. W., Salomon, L. J., & Papageorghiou, A. T. (2017) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.17246 · Cited by 266
Papastefanou, I., Wright, D., Lolos, M., Anampousi, K., Mamalis, M., & Nicolaides, K. H. (2021) · Ultrasound in Obstetrics & Gynecology · doi:10.1002/uog.23118 · Cited by 40
Self-citationSouka, A. P., Pilalis, A., Papastefanou, I., Salamalekis, G., & Kassanos, D. (2012) · Prenatal Diagnosis · doi:10.1002/pd.3976 · Cited by 21
Karim, J. N., Campbell, H., Pandya, P., Wilson, E. C. F., Alfirevic, Z., Chudleigh, T., Duff, E., Fisher, J., Goodman, H., Hinton, L., et al. (2025) · Health Technology Assessment · doi:10.3310/nltp7102 · Cited by 5
Self-citation
Metadata
- Authors
- Nicolaides, K. H.
- Venue
- Prenatal Diagnosis
- Publisher
- Wiley
- Published
- 2011-01
- Volume
- 31
- Issue
- 1
- Pages
- 3-6
- ISSN
- 0197-3851 (ISSN-L)
- 1097-0223
- OpenAlex
- W2073149084
- Cited by
- 242
- References
- 1
- FWCI
- 22.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A model for a new pyramid of prenatal care based on the 11 to 13 weeks' assessment. https://app.cochat.ai/papers/10.1002/pd.2685
- The paper
- Nicolaides, K. H. (2011). A model for a new pyramid of prenatal care based on the 11 to 13 weeks' assessment. Prenatal Diagnosis. https://doi.org/10.1002/pd.2685
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.